Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DR26FPV8K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,981
Award facts
- Contract value 100% obligated
- $38,980.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,980.52 to AmerisourceBergen Drug Corp for the supply of Kesimpta 20 mg/0.4 ml pen injectors on November 12, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), represents a single transaction within the company's broader pharmaceutical supply agreement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of November 13, 2025. No set-aside designation was used for this award, indicating it was competitively awarded.
Kesimpta is a specialty biologic medication used in the treatment of multiple sclerosis and other autoimmune conditions, reflecting the nature of specialized pharmaceutical products that AmerisourceBergen supplies to support military and federal healthcare systems. AmerisourceBergen's SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide. This delivery order exemplifies the ongoing operational demand for specialty medications within the federal medical supply chain to support military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FPV8K?
SPE2DR26FPV8K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FPV8K worth?
The government has obligated $38,981 on SPE2DR26FPV8K.
Is contract SPE2DR26FPV8K an order under another contract?
Yes. SPE2DR26FPV8K is a delivery order under SPE2DR25D1034, an indefinite delivery contract.
Was contract SPE2DR26FPV8K competed?
The extent of competition for SPE2DR26FPV8K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award